Wegovy is FDA-approved specifically for chronic weight management at a higher dose of 2.4 mg per week
This is the same pattern behind end-of-week hunger returning on these medications
Factors such as Medicaid coverage, income levels, age, and healthcare infrastructure play a crucial role in determining who can currently benefit from these medications, and addressing these disparities will be key to maximizing access to GLP-1 therapies in the years ahead
During ongoing weight loss, high-precision 3D body scanning may help track body-composition trends, while metabolic testing and analysis may add information about resting energy needs as weight changes
How could the ongoing investigation into the use of GLP-1 agonists for Type 1 diabetes shape future treatment options, and what ethical considerations might arise from prescribing these medications off-label
The one clear fact was that patients with duodenal ulcers gave an exaggerated secretory response to histamine, the basis of a diagnostic test' (Black)
